CC · Chemours Co
$15.62
-0.26 (-1.64%)
At close · Aug 28
View the 10-K filed Feb 24, 2026
Customer concentration
— top customer 7% of receivables
One customer — 7% of receivables (December 31, 2025)
“At December 31, 2025, one individual customer balance represented approximately 7% of our total outstanding accounts and notes receivable balance.”
Market Cap
$2.37B
Shares
150.50M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$15.62
Open$16.08
Day$15.47–16.22
52W close$10.48–27.94
Avg vol 30d2.6M
Short int13.5M · 9.0% float · 3.2d
Short vol62%
Last earningsAug 5, 2026
DataJan 2020–Aug 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 5, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.39
Technical
price trend
50 / 200-day cross
Death cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
−11%
below
RSI (14)
44
neutral
MACD trend
Positive
52-week position
29%
mid-range
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−10%
trailing
YTD return
+32%
this year
Relative strength
−25%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
Death cross
50d $17 › 200d $18 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +81 funds added
Insider flow
Accumulating
Net +$488.6K over 90 days · 0% sells
Short interest
Rising
9.00% of float · ▲ +5.9% MoM · 3.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
473 holders — near 3-yr high, broad support
Squeeze score
56
elevated · 0–100
Fundamentals
Revenue growth
+7%
Y/Y
Gross margin
14%
contracting
EPS growth
−659%
Y/Y
Free cash flow
$51.0M
Buyback
$441.0M
remaining
Balance sheet
$3.5B
net debt
Quant / Vol
risk profile
Volatility
63%
annualized · 1-yr
Max drawdown
−48%
past year
ATR
5.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 5, 2026
third quarter
TSS's adjusted EBITDA
Non-GAAP
$125M – $140M
TT's adjusted EBITDA
Non-GAAP
$70M – $80M
Corporate expenses
$40M – $45M
Consolidated adjusted EBITDA
Non-GAAP
$175M – $205M
Free cash flow
at least $50M
Consolidated adjusted EBITDA
$175M – $205M
Capital expenditures
$65M
full year 2026
Adjusted EBITDA
Non-GAAP
Initiated
$775M – $825M
Net sales
Initiated
1% – 5%
Adjusted EBITDA
Initiated
$775M – $825M
full year
Capital expenditures
$250M – $280M
this year
Free cash flow guidance above 25%
at least 25%
long-term
Free cash flow conversion
40%
Prior guidance
period ended
· from the Earnings Call filed Mar 31, 2026
TSS adjusted EBITDA
· second quarter
$210M – $225M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
Death cross
Bearish
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
−11%
Bearish
RSI (14)
44
Neutral
MACD trend
Positive
Bullish
52-week position
29%
Neutral
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
Death cross
50d $17 › 200d $18 — 200d above 50d
Institutional flow
Accumulating
+4% holders QoQ · +81 funds added
Insider flow
Accumulating
Net +$488.6K over 90 days · 0% sells
Short interest
Rising
9.00% of float · ▲ +5.9% MoM · 3.2 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
473 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $10
Now $16 · 29%
Range high $28
vs 200-day avg -13%
vs 50-day avg -11%
50-day below 200-day death cross
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA margin non-GAAP | 36% | Three Months Ended June 30, 2026 filing | — |
|
|
|||
| Segment Adjusted EBITDA non-GAAP | $287M | Three Months Ended June 30, 2026 filing | -5.6% |
|
|
|||
| Thermal & Specialized Solutions Adjusted EBITDA margin non-GAAP | 36% | Three Months Ended June 30, 2026 filing | — |
| Adjusted EBITDA non-GAAP | $416M | Six Months Ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Adjusted Net Income $105M
-$1M Net income attributable to non-controlling interests
+$273M Interest expense, net
+$320M Depreciation and amortization
+$36M All remaining provision for income taxes
= Adjusted EBITDA $733M
|
|||
| APM Adjusted EBITDA non-GAAP | 26M | Q2 2026 | — |
|
|
|||
| Free Cash Flow Conversion non-GAAP | 5% | Six Months Ended June 30, 2026 | — |
|
|
|||
| Free Cash Flows non-GAAP | $21M | Six Months Ended June 30, 2026 | — |
|
|
|||
| Total liquidity | 1.6B | Q2 2026 | — |
| TSS Adjusted EBITDA non-GAAP | 213M | Q2 2026 | — |
|
|
|||
| TSS Adjusted EBITDA Margin non-GAAP | 36% | Q2 2026 | — |
|
|
|||
| TT Adjusted EBITDA non-GAAP | 48M | Q2 2026 | — |
|
|
|||
| TT Adjusted EBITDA Margin non-GAAP | 7% | Q2 2026 | — |
|
|
|||
| Total debt principal, net | $3.62B | March 31, 2026 | — |
| Adjusted basic earnings per share of common stock non-GAAP | $0.95 | Year Ended December 31, 2025 | — |
| Adjusted diluted earnings per share of common stock non-GAAP | $0.95 | Year Ended December 31, 2025 | — |
| Adjusted Net Income non-GAAP | 143M | FY 2025 | — |
| APM Adjusted EBITDA Margin non-GAAP | 9% | FY 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CC
this stock
Chemours Co
|
$2.37B | +32.5% | +7.4% | — | 9.0% |
|
LIN
Linde PLC
|
$223.74B | +13.8% | +3.0% | 31.3 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$124.58B | +5.5% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.55B | +6.5% | +2.1% | 31.8 | 2.6% |
|
ECL
Ecolab Inc.
|
$80.15B | +8.9% | +2.2% | 38.4 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CC | -2.2% | -6.0% | -10.3% | -6.0% | +32.5% |
| SPY | +1.1% | +4.0% | +14.7% | +3.2% | +13.1% |
| vs SPY | -3.3% | -9.9% | -25.0% | -9.2% | +19.4% |
Capital returns
Latest dividend
$0.088
/ share · ex Aug 14, 2026
Paid (TTM)
$0.352
/ share · 4 payouts
Dividend yield (TTM, derived)
2.25%
Buyback program
· as of Dec 31, 2025
Authorized
$1.00B
Spent (derived)
$559.00M
Remaining
$441.00M
Spent
Remaining
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1627223
CUSIP
163851108
13F (30d)
343 filings
341 filers
Visit website
Investor relations